This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Connected Drug Delivery Devices Market

Market Insights on Connected Drug Delivery Devices covering sales outlook, demand forecast & up-to-date key trends

Connected Drug Delivery Devices Market By Product Type (Inhalation Devices, Injectable Devices, Handheld Injectable Devices, Wearable Injectable Devices), End User (Hospitals, Clinics, Home Care), Technology (Bluetooth, Near Field Communication), Application (Anaphylaxis, Cardiovascular, Diabetes) & Region - Forecast 2022 - 2028

Connected Drug Delivery Devices Market Snapshot

[228 Pages Report] The global Connected Drug Delivery Devices Market size was estimated at US$ 330 Mn in 2021, and is expected to reach US$ 1.6 Bn by 2028, expanding at a stellar CAGR of 23.6%.

Connected Drug Delivery Devices Market Size (2022)

US$ 448 Mn

Sales Forecast (2028)

US$ 1.6 Bn

Projected Market Growth Forecast (2022-2028)

23.6% CAGR

Regional Market With Highest Share

North America – 51.5%

Sales of connected drug delivery devices contribute 3.7% share to the global novel drug delivery system market. Drug delivery in nanotechnology has been extensively researched on, and this is expected to spawn new innovative drug delivery methods going ahead.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

25.73%

H1, 2022 Projected

23.59%

H1, 2022 Outlook

22.79%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 80 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 294 ↓

With the influence of various macroeconomic, industrial and regulatory variables, the comparative analysis of market growth rate of global connected drug delivery devices market has been studied by Future Market Insights.

As per the study, the global market will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 80 BPS, and, a decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 294 Basis Point Share (BPS).

Key barriers to the broader adoption of connected devices include data privacy laws that may prevent data sharing with HCPs in some countries, as well as the need to demonstrate that the tools are consistently used and generate a high-quality and reproducible database. These factors impose a negative impact as observed in the BPS value change.

However, there are some positive factors that will help push the market growth in the upcoming years which includes growing development of connected drug delivery systems with features like adherence trackers, patient education tools, dose reminders, patient diaries to gather patient-reported outcomes, and monitoring systems with interfaces between patients and healthcare professionals (HCPs).

This will enable patient monitoring and counselling in a home setting, thereby providing lucrative growth opportunities for the market players.

Demand Analysis of Connected Drug Delivery Devices (2015 to 2021) Vs Market Predictions (2022 to 2028)

The healthcare industry has seen major changes over the past years, and most of these were driven by increased technological proliferation in the industry. Drug delivery has become one of the most researched areas in the healthcare industry, and since patient engagement has become essential in the medical sector, demand for connected drug delivery devices has also risen significantly.

Injectable drug delivery devices are expected to be most popular over the next few years as they have multiple functionalities and can be used for drug tracking, drug delivery, as well as drug identification. Rising preference for these among the population is expected to boost sales of injectable drug delivery devices over the forecast period.

Connected Drug Delivery Devices Market Download Report Brochure

Rising penetration of IoT (Internet of Things) in the medical industry, advances in drug delivery nanotechnology, innovative product launches, increasing awareness about connected drug therapy, and rising trend of home care are some of the major factors that are positively influencing the sales of connected drug delivery devices across the globe.

Demand for connected drug delivery devices increased at a phenomenal CAGR of 26.3% from 2015 to 2021, and is slated to continue surging at 23.6% CAGR from 2022 to 2028,

Which Regions Should Connected Drug Delivery Device Manufacturers Focus On?

This research details the global connected drug delivery devices industry across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).

The North America connected drug delivery devices market, which is set to hold a significant market share of 51.5% in 2022, is expected to maintain this dominance over the forecast period as well. Increasing healthcare expenditure and rising awareness are majorly propelling the sales of connected drug delivery devices in the region.

The market for connected drug delivery devices in Europe holds the second-highest market share of over 28%. Demand for connected drug delivery products in Europe is expected to rise at the fastest CAGR among all regions. Rapid growth can be attributed to increasing prevalence of chronic diseases in the region.

Market growth of connected drug delivery devices in East Asia, South Asia, and the Pacific is expected to see limited due to major factors influencing the sales and adoption of connected drug delivery devices. Majorly, high cost of connected drug delivery devices is restraining the market potential in these regions.

Connected drug delivery system manufacturers can target these regions to gain from the untapped market potential with competitive pricing and affordable products.

The connected drug delivery devices market in the MEA region, which merely contributes 1.9% to the global market share, is expected to rise at a sluggish CAGR. This is majorly due to high costs and little to no awareness about connected drug delivery devices.

However, as the region develops, it would offer some good opportunities for manufacturers and distributors of connected drug delivery devices to boost their sales.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Connected Drug Delivery Devices Market - Country-wise Analysis

What is the U.S. Connected Drug Delivery Systems Market Stance?

The healthcare industry in the U.S. has been experiencing great growth over the past few years, and is expected to continue to do so over the forecast period as well. The nation has seen substantial increase in the adoption of connected drug delivery equipment.

Factors such as high per capita healthcare spending, rising adoption of new medical technologies, and increasing awareness about the adverse effects of non-compliance with drug therapy are majorly driving the sales of connected drug delivery products in the U.S.

How are Sales of Connected Drug Delivery Devices Expected to Perform in Japan?

The Japanese connected drug delivery devices market in 2022 is slated to hold 5.1% share of the global market. The nation is always regarded as one of the most technologically advanced in the world, and it only befits that Japan is leading the adoption of healthcare and medical technologies than most nations.

Japan has very high technological proliferation in the healthcare sector, and this makes it a very lucrative market for connected drug delivery device suppliers.  Demand for connected drug delivery equipment is also expected to be boosted by the rising geriatric population in Japan, which is also fuelling demand for home care solutions in the nation.

Sales of connected drug delivery systems are expected to see a rise over the forecast period as the popularity and effectiveness of these devices rise.

Connected Drug Delivery Devices Market - Category-wise Analysis

Which Technology is Most Used for Connected Drug Delivery Devices?

Connected drug delivery devices work majorly on two technologies - Bluetooth and near field communication (NFC). Bluetooth technology connected drug delivery devices contribute more than 3/5 of the global revenue of the industry. This segment is expected to further grow as advancements in Bluetooth technology pace over the coming years. Low cost of implementation and easy availability make Bluetooth the first choice for many connected drug delivery device manufacturers.

However, NFC technology connected drug delivery devices are expected to rise at the fastest CAGR as these devices are becoming popular for drug identification and tracking purposes, along with having more flexibility and versatility than Bluetooth-operated devices.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Connected Drug Delivery Devices Market - COVID-19 Impact Analysis

The COVID-19 pandemic of 2020 took the world by storm and exposed the healthcare system. This fueled the already increasing trend of revolutionizing the healthcare infrastructure to better accommodate technological proliferation.

While most markets toppled across the globe in 2020, the connected drug delivery devices market showed good growth even in the face of tough times where most of the world was in lockdown.

Demand for connected drug delivery devices was driven by sudden surge in demand for drug delivery solutions for home care use, since people were prohibited to go out under lockdown restrictions. This led to an increase in the adoption of connected drug delivery devices technology, which has been gaining momentum over the past few years.

Sales of connected drug delivery device producers are expected to continue to grow in the post-pandemic era as awareness about their uses increases on a global scale.

Connected Drug Delivery Devices Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2015-2021

Market Analysis

US$ Mn for Value, Units for Volume

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Product Type
  • End User
  • Application
  • Technology
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments of Connected Drug Delivery Devices Industry Survey

Connected Drug Delivery Devices Market by Product Type:

  • Inhalation Devices
  • Injectable Devices
    • Handheld Injectable Devices
    • Wearable Injectable Devices

Connected Drug Delivery Devices Market by End User:

  • Hospitals
  • Clinics
  • Home Care

Connected Drug Delivery Devices Market by Application:

  • Anaphylaxis
  • Cardiovascular
  • Diabetes
  • Hormone Replacement
  • Others

Connected Drug Delivery Devices Market by Technology:

  • Bluetooth Drug Delivery Devices
  • Near Field Communication Drug Delivery Devices

Connected Drug Delivery Devices Market by Region:

  • North America Connected Drug Delivery Devices Market
  • Latin America Connected Drug Delivery Devices Market
  • Europe Connected Drug Delivery Devices Market
  • East Asia Connected Drug Delivery Devices Market
  • South Asia & Pacific Connected Drug Delivery Devices Market
  • Middle East & Africa (MEA) Connected Drug Delivery Devices Market

Frequently Asked Questions

Currently, the global connected drug delivery devices market is worth US$ 448 Mn.

The connected drug delivery devices market in North America will hold a dominant market share of 51.5%.

The connected drug delivery devices market is predicted to progress at a CAGR of 23.6% from 2022 to 2028.

Bayer AG., Propeller Health, West Pharmaceutical Services Inc., 3M Company, OPKO Health, Sagentia (Science Group), and Care TRx, CeQur SA, are some of the major players profiled in this connected drug delivery devices industry analysis.

FMI study suggests that the connected drug delivery devices market will reach a value of US$ 1.6 Bn by 2028.

Table of Content

1. Executive Summary

   1.1. Market Overview

   1.2. Market Analysis

   1.3. FMI Analysis and Recommendations

   1.4. Wheel of Fortune

2. Market Introduction

   2.1. Market Taxonomy

   2.2. Market Definition

   2.3. Market Inclusion and Exclusion

3. Connected Drug Delivery Devices Market Opportunity Analysis

   3.1. Macro-Economic Factors

   3.2. Opportunity Analysis

   3.3. Drivers

      3.3.1. Supply Side Drivers

      3.3.2. Demand Side Drivers

   3.4. Restraints

   3.5. Trends

4. Global Economic Outlook

   4.1. Global Gross Domestic Product by Region & Country

   4.2. Global Healthcare Market Indicator

5. North America Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   5.1. Introduction

   5.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2028

      5.2.1. U.S.

      5.2.2. Canada

   5.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      5.3.1. Inhalation Devices

      5.3.2. Injectable Devices

         5.3.2.1. Handheld Injectable Devices

         5.3.2.2. Wearable Injectable Devices

   5.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      5.4.1. Bluetooth

      5.4.2. Near Field Communication

   5.5. Market Size (US$ Mn) Forecast By Application, 2013-2028

      5.5.1. Anaphylaxis

      5.5.2. Cardiovascular

      5.5.3. Diabetes

      5.5.4. Hormone Replacement

      5.5.5. Others

   5.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      5.6.1. Hospitals

      5.6.2. Clinics

      5.6.3. Homecare

   5.7. Market Attractiveness Analysis

      5.7.1. By Product Type

      5.7.2. Technology

      5.7.3. By Application

      5.7.4. By End User

      5.7.5. By Country

   5.8. Drivers and Restraints: Impact Analysis

   5.9. Key Market Participants – Intensity Mapping

6. Latin America Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   6.1. Introduction

   6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2028

      6.2.1. Brazil

      6.2.2. Mexico

      6.2.3. Argentina

      6.2.4. Rest of Latin America

   6.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      6.3.1. Inhalation Devices

      6.3.2. Injectable Devices

         6.3.2.1. Handheld Injectable Devices

         6.3.2.2. Wearable Injectable Devices

   6.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      6.4.1. Bluetooth

      6.4.2. Near Field Communication

   6.5. Market Size (US$ Mn) Forecast By Application, 2013-2028

      6.5.1. Anaphylaxis

      6.5.2. Cardiovascular

      6.5.3. Diabetes

      6.5.4. Hormone Replacement

      6.5.5. Others

   6.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      6.6.1. Hospitals

      6.6.2. Clinics

      6.6.3. Homecare

   6.7. Market Attractiveness Analysis

      6.7.1. By Product Type

      6.7.2. Technology

      6.7.3. By Application

      6.7.4. By End User

      6.7.5. By Country

   6.8. Drivers and Restraints: Impact Analysis

   6.9. Key Market Participants – Intensity Mapping

7. Western Europe Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   7.1. Introduction

   7.2. Market Size (US$ Mn) Forecast By Country, 2013-2028

      7.2.1. Germany

      7.2.2. U.K

      7.2.3. France

      7.2.4. Italy

      7.2.5. Spain

      7.2.6. Rest of Western Europe

   7.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      7.3.1. Inhalation Devices

      7.3.2. Injectable Devices

         7.3.2.1. Handheld Injectable Devices

         7.3.2.2. Wearable Injectable Devices

   7.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      7.4.1. Bluetooth

      7.4.2. Near Field Communication

   7.5. Market Size (US$ Mn) Forecast By Application, 2013-2028

      7.5.1. Anaphylaxis

      7.5.2. Cardiovascular

      7.5.3. Diabetes

      7.5.4. Hormone Replacement

      7.5.5. Others

   7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      7.6.1. Hospitals

      7.6.2. Clinics

      7.6.3. Homecare

   7.7. Market Attractiveness Analysis

      7.7.1. By Product Type

      7.7.2. Technology

      7.7.3. By Application

      7.7.4. By End User

      7.7.5. By Country

   7.8. Drivers and Restraints: Impact Analysis

   7.9. Key Market Participants – Intensity Mapping

8. Eastern Europe Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   8.1. Introduction

   8.2. Market Size (US$ Mn) Forecast By Country, 2013-2028

      8.2.1. Russia

      8.2.2. Poland

      8.2.3. Rest of Eastern Europe

   8.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      8.3.1. Inhalation Devices

      8.3.2. Injectable Devices

         8.3.2.1. Handheld Injectable Devices

         8.3.2.2. Wearable Injectable Devices

   8.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      8.4.1. Bluetooth

      8.4.2. Near Field Communication

   8.5. Market Size (US$ Mn) Forecast By Application, 2013-2028

      8.5.1. Anaphylaxis

      8.5.2. Cardiovascular

      8.5.3. Diabetes

      8.5.4. Hormone Replacement

      8.5.5. Others

   8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      8.6.1. Hospitals

      8.6.2. Clinics

      8.6.3. Homecare

   8.7. Market Attractiveness Analysis

      8.7.1. By Product Type

      8.7.2. Technology

      8.7.3. By Application

      8.7.4. By End User

      8.7.5. By Country

   8.8. Drivers and Restraints: Impact Analysis

   8.9. Key Market Participants – Intensity Mapping

9. Asia Pacific Excluding China & Japan Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   9.1. Introduction

   9.2. Market Size (US$ Mn) Forecast By Country, 2013-2028

      9.2.1. India

      9.2.2. Australia and New Zealand

      9.2.3. ASEAN

      9.2.4. Rest of APECJ

   9.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      9.3.1. Inhalation Devices

      9.3.2. Injectable Devices

         9.3.2.1. Handheld Injectable Devices

         9.3.2.2. Wearable Injectable Devices

   9.4. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      9.4.1. Bluetooth

      9.4.2. Near Field Communication

   9.5. Market Size (US$ Mn) Forecast By Application, 2013-2028

      9.5.1. Anaphylaxis

      9.5.2. Cardiovascular

      9.5.3. Diabetes

      9.5.4. Hormone Replacement

      9.5.5. Others

   9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      9.6.1. Hospitals

      9.6.2. Clinics

      9.6.3. Homecare

   9.7. Market Attractiveness Analysis

      9.7.1. By Product Type

      9.7.2. Technology

      9.7.3. By Application

      9.7.4. By End User

      9.7.5. By Country

   9.8. Drivers and Restraints: Impact Analysis

   9.9. Key Market Participants – Intensity Mapping

10. China Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   10.1. Introduction

   10.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      10.2.1. Inhalation Devices

      10.2.2. Injectable Devices

         10.2.2.1. Handheld Injectable Devices

         10.2.2.2. Wearable Injectable Devices

   10.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      10.3.1. Bluetooth

      10.3.2. Near Field Communication

   10.4. Market Size (US$ Mn) Forecast By Application, 2013-2028

      10.4.1. Anaphylaxis

      10.4.2. Cardiovascular

      10.4.3. Diabetes

      10.4.4. Hormone Replacement

      10.4.5. Others

   10.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      10.5.1. Hospitals

      10.5.2. Clinics

      10.5.3. Homecare

   10.6. Market Attractiveness Analysis

      10.6.1. By Product Type

      10.6.2. Technology

      10.6.3. By Application

      10.6.4. By End User

   10.7. Drivers and Restraints: Impact Analysis

   10.8.Key Market Participants – Intensity Mapping

11. Japan Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   11.1.Introduction

   11.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      11.2.1. Inhalation Devices

      11.2.2. Injectable Devices

         11.2.2.1. Handheld Injectable Devices

         11.2.2.2. Wearable Injectable Devices

   11.3. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      11.3.1. Bluetooth

      11.3.2. Near Field Communication

   11.4. Market Size (US$ Mn) Forecast By Application, 2013-2028

      11.4.1. Anaphylaxis

      11.4.2. Cardiovascular

      11.4.3. Diabetes

      11.4.4. Hormone Replacement

      11.4.5. Others

   11.5. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      11.5.1. Hospitals

      11.5.2. Clinics

      11.5.3. Homecare

   11.6. Market Attractiveness Analysis

      11.6.1. By Product Type

      11.6.2. Technology

      11.6.3. By Application

      11.6.4. By End User

   11.7. Drivers and Restraints: Impact Analysis

   11.8. Key Market Participants – Intensity Mapping

12. Middle East and Africa Connected Drug Delivery Devices Market Analysis and Forecast 2013–2028

   12.1. Introduction

   12.2. Regional Market Trends

   12.3. Market Size (US$ Mn) Forecast By Country, 2013-2028

      12.3.1. GCC Countries

      12.3.2. South Africa

      12.3.3. Rest of Middle East and Africa

   12.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2028

      12.4.1. Inhalation Devices

      12.4.2. Injectable Devices

         12.4.2.1. Handheld Injectable Devices

         12.4.2.2. Wearable Injectable Devices

   12.5. Historical Market Size (US$ Mn) Trend Analysis By Technology, 2013-2021

      12.5.1. Bluetooth

      12.5.2. Near Field Communication

   12.6. Market Size (US$ Mn) Forecast By Application, 2013-2028

      12.6.1. Anaphylaxis

      12.6.2. Cardiovascular

      12.6.3. Diabetes

      12.6.4. Hormone Replacement

      12.6.5. Others

   12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2028

      12.7.1. Hospitals

      12.7.2. Clinics

      12.7.3. Homecare

   12.8. Market Attractiveness Analysis

      12.8.1. By Product Type

      12.8.2. Technology

      12.8.3. By Application

      12.8.4. By End User

      12.8.5. By Country

   12.9. Drivers and Restraints: Impact Analysis

   12.10. Key Market Participants – Intensity Mapping

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis

   15.1.Market Structure by Tier

   15.2.Market Share Analysis (2016) for Top Players, By Region

16. Competition Analysis

   16.1.Competition Dashboard

   16.2.Competitors Deep Dive

      16.2.1. Bayer AG

         16.2.1.1. Overview

         16.2.1.2. Product and Application Portfolio

         16.2.1.3. Production Footprint

         16.2.1.4. Sales Footprint

         16.2.1.5. Channel Footprint

         16.2.1.6. Strategy

            16.2.1.6.1. Marketing Strategy

            16.2.1.6.2. Product Strategy

            16.2.1.6.3. Channel Strategy

      16.2.2. Propeller Health

         16.2.2.1. Overview

         16.2.2.2. Product and Application Portfolio

         16.2.2.3. Production Footprint

         16.2.2.4. Sales Footprint

         16.2.2.5. Channel Footprint

         16.2.2.6. Strategy

            16.2.2.6.1. Marketing Strategy

            16.2.2.6.2. Product Strategy

            16.2.2.6.3. Channel Strategy

      16.2.3. West Pharmaceutical Services, Inc.

         16.2.3.1. Overview

         16.2.3.2. Product and Application Portfolio

         16.2.3.3. Production Footprint

         16.2.3.4. Sales Footprint

         16.2.3.5. Channel Footprint

         16.2.3.6. Strategy

            16.2.3.6.1. Marketing Strategy

            16.2.3.6.2. Product Strategy

            16.2.3.6.3. Channel Strategy

      16.2.4. 3M Company

         16.2.4.1. Overview

         16.2.4.2. Product and Application Portfolio

         16.2.4.3. Production Footprint

         16.2.4.4. Sales Footprint

         16.2.4.5. Channel Footprint

         16.2.4.6. Strategy

            16.2.4.6.1. Marketing Strategy

            16.2.4.6.2. Product Strategy

            16.2.4.6.3. Channel Strategy

      16.2.5. OPKO Health

         16.2.5.1. Overview

         16.2.5.2. Product and Application Portfolio

         16.2.5.3. Production Footprint

         16.2.5.4. Sales Footprint

         16.2.5.5. Channel Footprint

         16.2.5.6. Strategy

            16.2.5.6.1. Marketing Strategy

            16.2.5.6.2. Product Strategy

            16.2.5.6.3. Channel Strategy

      16.2.6. Sagentia (Science Group)

         16.2.6.1. Overview

         16.2.6.2. Product and Application Portfolio

         16.2.6.3. Production Footprint

         16.2.6.4. Sales Footprint

         16.2.6.5. Channel Footprint

         16.2.6.6. Strategy

            16.2.6.6.1. Marketing Strategy

            16.2.6.6.2. Product Strategy

            16.2.6.6.3. Channel Strategy

      16.2.7. Cohero Health

         16.2.7.1. Overview

         16.2.7.2. Product and Application Portfolio

         16.2.7.3. Production Footprint

         16.2.7.4. Sales Footprint

         16.2.7.5. Channel Footprint

         16.2.7.6. Strategy

            16.2.7.6.1. Marketing Strategy

            16.2.7.6.2. Product Strategy

            16.2.7.6.3. Channel Strategy

      16.2.8. Care TRx

         16.2.8.1. Overview

         16.2.8.2. Product and Application Portfolio

         16.2.8.3. Production Footprint

         16.2.8.4. Sales Footprint

         16.2.8.5. Channel Footprint

         16.2.8.6. Strategy

            16.2.8.6.1. Marketing Strategy

            16.2.8.6.2. Product Strategy

            16.2.8.6.3. Channel Strategy

      16.2.9. CeQur SA

         16.2.9.1. Overview

         16.2.9.2. Product and Application Portfolio

         16.2.9.3. Production Footprint

         16.2.9.4. Sales Footprint

         16.2.9.5. Channel Footprint

         16.2.9.6. Strategy

            16.2.9.6.1. Marketing Strategy

            16.2.9.6.2. Product Strategy

            16.2.9.6.3. Channel Strategy

      16.2.10. Biocorp Production SA

         16.2.10.1. Overview

         16.2.10.2. Product and Application Portfolio

         16.2.10.3. Production Footprint

         16.2.10.4. Sales Footprint

         16.2.10.5. Channel Footprint

         16.2.10.6. Strategy

            16.2.10.6.1. Marketing Strategy

            16.2.10.6.2. Product Strategy

            16.2.10.6.3. Channel Strategy

17. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028, By Region

   17.1. Introduction / Key Findings

   17.2. Market Size (US$ Mn) Forecast By Region

      17.2.1. North America

      17.2.2. Western Europe

      17.2.3. Eastern Europe

      17.2.4. Latin America

      17.2.5. Asia Pacific Excluding Japan And China

      17.2.6. China

      17.2.7. Japan

      17.2.8. Middle East and Africa

   17.3. Market Attractiveness Analysis By Region

18. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028, By Product Type

   18.1. Introduction/Key Finding

   18.2. Market Size (US$ Mn) Forecast By Product Type, 2013-2028

      18.2.1. Inhalation Devices

      18.2.2. Injectable Devices

         18.2.2.1. Handheld Injectable Devices

         18.2.2.2. Wearable Injectable Devices

   18.3. Market Attractiveness Analysis By Product Type

19. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028, By Technology

   19.1. Introduction/Key Finding

   19.2. Market Size (US$ Mn) Forecast By Technology, 2013-2028

      19.2.1. Bluetooth

      19.2.2. Near Field Communication

   19.3. Market Attractiveness Analysis By Technology

20. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028, By Application

   20.1. Introduction/Key Finding

   20.2. Market Size (US$ Mn) Forecast By Application, 2013-2028

      20.2.1. Anaphylaxis

      20.2.2. Cardiovascular

      20.2.3. Diabetes

      20.2.4. Hormone Replacement

      20.2.5. Others

   20.3. Market Attractiveness Analysis By Application

21. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028, By End User

   21.1. Introduction/Key Finding

   21.2.Market Size (US$ Mn) Forecast By End User, 2013-2028

      21.2.1. Hospitals

      21.2.2. Clinics

      21.2.3. Homecare

   21.3.Market Attractiveness Analysis By End User

22. Global Connected Drug Delivery Devices Market Analysis Forecast 2013–2028

   22.1.Market Value Share Analysis By All Segment

   22.2.Y-o-Y Growth Analysis By All Segment

   22.3.Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 02: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 03: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 04: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 05: North America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 06: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 07: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 08: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 09: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 10: Latin America Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 11: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 12: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 13: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 14: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 15: Western Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 16: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 17: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 18: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 19: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 20: Eastern Europe Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 21: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 22: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 23: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 24: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 25: APECJ Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 26: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 27: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 28: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 29: China Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 30: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 31: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 32: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 33: Japan Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 34: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Country

Table 35: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Product Type

Table 36: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 37: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Application

Table 38: MEA Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By End User

Table 39: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region

Table 40: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Product Type

Table 41: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Technology

Table 42: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Application

Table 43: Global Connected Drug Delivery Devices Market Value (US$ Mn) Analysis-and Opportunity Assessment 2013–2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: North America Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 02: North America Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 03: North America Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 03: North America Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 04: North America Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 06: North America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 07: U.S. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 08: Canada Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 08: Western Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 09: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 10: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 11: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 12: North America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 13: North America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 14: Latin America Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 15: Latin America Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 16: Latin America Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 17: Latin America Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 18: Latin America Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 19: Latin America Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 20: Brazil Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 21: Mexico Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 22: Argentina Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 23: Rest of Latin America Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 24: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 25: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 26: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 27: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 28: Latin America Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 29: Western Europe Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 30: Western Europe Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 31: Western Europe Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 32: Western Europe Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 33: Western Europe Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 34: U.K. Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 35: Germany Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 36: France Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 37: Italy Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 38: Spain Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 39: Rest of Western Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 40: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 41: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 42: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 43: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 44: Western Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 45: Eastern Europe Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 46: Eastern Europe Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 47: Eastern Europe Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 48: Eastern Europe Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 49: Eastern Europe Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 50: Eastern Europe Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 51: Russia Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 52: Poland Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 53: Rest of Eastern Europe Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 54: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 55: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 56: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 57: Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 58 : Eastern Europe Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 59: APECJ Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 60: APECJ Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 61: APECJ Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 62: APECJ Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 63: APECJ Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 64: APECJ Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 65: India Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 66: ANZ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 67: ASEAN Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 68: Rest of APECJ Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 69: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 70: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 71: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 72: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 73: APECJ Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 74: China Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 75: China Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 76: China Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 77: China Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 78: China Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 79: China Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 80: China Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 81: China Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 82: China Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 83: Japan Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 84: Japan Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 85: Japan Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 86: Japan Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 87: Japan Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 88: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 89: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 90: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 91: Japan Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 91: MEA Connected Drug Delivery Devices Market Value Share By Product Type (2022 E)

Figure 92: MEA Connected Drug Delivery Devices Market Value Share By Technology (2022 E)

Figure 93: MEA Connected Drug Delivery Devices Market Value Share By Country (2022 E)

Figure 94: MEA Connected Drug Delivery Devices Market Value Share By Application (2022 E)

Figure 95: MEA Connected Drug Delivery Devices Market Value Share By End User (2022 E)

Figure 96: MEA Connected Drug Delivery Devices Market Value Analysis and Forecast (US$ Mn), 2013-2028

Figure 97: South Africa Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 98: GCC Countries Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 100: Rest of MEA Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028

Figure 101: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 102: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 103: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 104: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 105: MEA Connected Drug Delivery Devices Market Attractiveness Analysis by Country, 2022-2028

Figure 106: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Region, 2022-2028

Figure 107: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Inhalation Devices

Figure 108: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Injectable Devices

Figure 109: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Product Type, 2022-2028

Figure 110: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Bluetooth

Figure 111: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By NFC

Figure 112: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Technology, 2022-2028

Figure 113: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Anaphylaxis

Figure 114: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Cardiovascular

Figure 115: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Diabetes

Figure 116: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Hormone Replacement

Figure 117: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Others

Figure 118: Global Connected Drug Delivery Devices Market Attractiveness Analysis by Application, 2022-2028

Figure 119: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Hospitals

Figure 120: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Clinics

Figure 121: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013–2028, By Homecare

Figure 122: Global Connected Drug Delivery Devices Market Attractiveness Analysis by End User, 2022-2028

Figure 123: Global Connected Drug Delivery Devices Market Value Analysis (US$ Mn), 2013-2028

Figure 124: Global Connected Drug Delivery Devices Market Absolute $ Opportunity, 2022 - 2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Ocular Drug Delivery System Market

Published : June 2021

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Connected Drug Delivery Devices Market